MusclePharm Corporation

MSLP

US6273352012

Investment Holding Companies

Market Closed - OTC Markets Other stock markets 15:28:56 2024-04-03 EDT			5-day change	1st Jan Change
0.000001 ^USD	-99.92%		-.--%	-.--%

2023	Second Motion for Exclusivity Period Extension Approved For MusclePharm Corporation	CI
2023	FitLife Brands, Inc. completed the acquisition of Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q).	CI

Brian Casutto, Executive Vice President, Sales and Marketing and Director of Musclepharm Corporation, Resigns

May 07, 2020 at 04:56 pm

Upon the approval of the Board of Directors of MusclePharm Corporation, on May 1, 2020, Brian Casutto, Executive Vice President, Sales and Marketing, and a Director of the company, resigned from all of his current roles with the company, effective immediately.

Latest news about MusclePharm Corporation

Second Motion for Exclusivity Period Extension Approved For MusclePharm Corporation	23-10-18	CI
FitLife Brands, Inc. completed the acquisition of Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q).	23-10-09	CI
Motion for Asset Sale Approved for MusclePharm Corporation	23-10-03	CI
FitLife Brands, Inc. entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million.	23-09-26	CI
Stalking Horse Agreement Filed by MusclePharm Corporation	23-09-08	CI
Musclepharm Corporation Announces Resignation of Paul Karr as Director	23-08-31	CI
Second Amended Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation	23-08-28	CI
First Amended Disclosure Statement Approved for MusclePharm Corporation	23-08-28	CI
Bidding Procedure Approved for MusclePharm Corporation	23-08-17	CI
Musclepharm Corporation Terminates Gary Shirshac as Chief Financial Officer	23-07-19	CI
First Amended Reorganization Plan and DIsclosure Statement Filed by MusclePharm Corporation	23-06-19	CI
Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation	23-05-26	CI
Motion for Asset Sale Filed by MusclePharm Corporation	23-05-12	CI
First Motion for Exclusivity Period Extension Approved For MusclePharm Corporation	23-05-10	CI
MusclePharm Corporation has withdrawn its IPO in the amount of $10 million.	23-04-16	CI
First Motion for Exclusivity Period Extension Filed by MusclePharm Corporation	23-04-10	CI
DIP Financing Approved for MusclePharm Corporation	23-03-08	CI
Amended DIP Financing Approved for MusclePharm Corporation	23-01-23	CI
Interim DIP Financing Approved for MusclePharm Corporation	23-01-09	CI
MusclePharm Corporation Filed for Bankruptcy	22-12-15	CI
MusclePharm Appoints Gary C. Shirshac as Interim CFO	22-09-29	MT
MusclePharm Corporation Appoints Gary C. Shirshac to Serve as Interim Chief Financial Officer	22-09-29	CI
MusclePharm Chief Financial Officer Eric Chin Resigns	22-08-23	MT
MusclePharm Corporation Announces Appointment of Eric Chin as Chief Financial Officer of the Company	22-07-28	CI
MusclePharm Corporation Announces Board Changes	22-07-28	CI

Chart MusclePharm Corporation

Duration

Period

More charts

Company Profile

MusclePharm Corporation is a United States company. The Company has no operation nor generated any revenue.

Sector

Investment Holding Companies

More about the company

Sector Shell Companies

	1st Jan change	Capi.
MUSCLEPHARM CORPORATION	-.--%	33
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+167.09%	8.26B
CHURCHILL CAPITAL CORP VII	+2.19%	982M
APPLE ISPORTS GROUP, INC.	+41.91%	883M
PERELLA WEINBERG PARTNERS	+24.45%	814M
ARES ACQUISITION CORPORATION II	+1.96%	665M
E7 GROUP	+2.33%	653M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ADMIRAL ACQUISITION LIMITED	+8.06%	525M
CAPITOL INVESTMENT CORP. VII	-.--%	500M

Shell Companies

MusclePharm Corporation

Equities

MSLP

US6273352012

Investment Holding Companies

Brian Casutto, Executive Vice President, Sales and Marketing and Director of Musclepharm Corporation, Resigns

Latest news about MusclePharm Corporation

Chart MusclePharm Corporation

Company Profile

Sector Shell Companies